Security key
44930G107
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 20,080,347
- Total 13F value
- $4,125,473,068
- Share change
- +567,922
- Put/Call ratio
- 28%
- SEC-reported price per share
- $205.44
- Number of holders
- 277
- Value change
- +$114,043,017
- Number of buys
- 131
- Number of sells
- 119
- Shares outstanding
- 25,012,080
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2021
Institutions
277
Top holders
10
ICUI full security history
Ownership snapshot
Full 13F holder table
ICU MEDICAL INC/DE SEC filings
ICU MEDICAL INC/DE company facts
Broader feeds
Ownership snapshot
Top reported holders of ICUI - ICU MEDICAL INC/DE - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PRICE T ROWE ASSOCIATES I...
Disclosed value leader
PRICE T ROWE ASSOCIATES I...
Comparable rows
15/15
Latest evidence
31 Dec 2020
13F
Lead comparable stake: 11%
Showing 1-6 of 15 holder rows.
Quick read
PRICE T ROWE ASSOCIATES INC /MD/ leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PRICE T ROWE ASSOCIATES INC /MD/'s linked filing trail.
Comparable ownership
Top 5
PRICE T ROWE ASSOCIATES INC /MD/
11%
Janus Henderson Group Ltd.
10%
VANGUARD GROUP INC
7.2%
BlackRock Finance, Inc.
6.6%
NUANCE INVESTMENTS, LLC
3.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
11%
|
$566,332,000
2,640,364 shares
|
— | 31 Dec 2020 |
| Janus Henderson Group Ltd. |
13F
Company
|
10%
|
$562,756,000
2,623,694 shares
|
— | 31 Dec 2020 |
| VANGUARD GROUP INC |
13F
Company
|
7.2%
|
$387,232,000
1,805,362 shares
|
— | 31 Dec 2020 |
| BlackRock Finance, Inc. |
13F
Company
|
6.6%
|
$356,249,000
1,660,914 shares
|
— | 31 Dec 2020 |
| NUANCE INVESTMENTS, LLC |
13F
Company
|
3.6%
|
$193,359,000
901,483 shares
|
— | 31 Dec 2020 |
| JPMORGAN CHASE & CO |
13F
Company
|
3.1%
|
$165,532,000
771,746 shares
|
— | 31 Dec 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
277
Shares
20,080,347
Rows available
277
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2021 vs Q1 2021 Across Filers
Q1 2021 holders
277
Q1 2021 holders
277
Holder diff
0
| Investor | Q1 2021 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q1 2021 value | Q1 2021 value | Value change | Value Chg % |
|---|